Real‐world effectiveness and tolerability of cenobamate in drug‐resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom

Real‐world effectiveness and tolerability of cenobamate in drug‐resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom

Abstract Objective Investigate real‐world outcomes in drug‐resistant epilepsy (DRE) patients treated with cenobamate as adjunctive treatment to other antiseizure medications (ASMs) within the Early Access Programs (EAP) in Germany, France, and the United Kingdom. Methods DRE adults with uncontrolled...

Full description

Saved in:
Bibliographic Details
Main Authors: Sylvain Rheims, Bernhard J. Steinhoff, Edouard Hirsch, Felix Rosenow, Arnaud Biraben, Rhys Thomas, Alessandro Lovera, Paola Lipone, Alessandro Comandini, Caroline Benoist, Elena Alvarez Baron, John Paul Leach, Karthinathan Thangavelu, Agnese Cattaneo
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Epilepsia Open
Subjects:
antiseizure medication
cenobamate
responder rate
seizure freedom
Online Access:https://doi.org/10.1002/epi4.70021
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/epi4.70021

Similar Items